{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:53:20Z","timestamp":1785333200292,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.clcc.2015.07.001","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T10:42:23Z","timestamp":1437907343000},"page":"37-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies"],"prefix":"10.1016","volume":"15","author":[{"given":"Sangeetha M.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7120-6482","authenticated-orcid":false,"given":"Maxwell T.","family":"Vergo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Paice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene B.","family":"Helenowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al B.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Mulcahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halla S.","family":"Nimeiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Harden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2015.07.001_bib1","first-page":"201593","article-title":"Oxaliplatin-induced neuropathy in colorectal cancer","volume":"2011","author":"Weickhardt","year":"2011","journal-title":"J\u00a0Oncol"},{"key":"10.1016\/j.clcc.2015.07.001_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1345\/aph.1E319","article-title":"Oxaliplatin-associated neuropathy: a review","volume":"39","author":"Cersosimo","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clcc.2015.07.001_bib3","first-page":"9","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"249","author":"Quasthoff","year":"2002","journal-title":"J\u00a0Neurol"},{"issue":"5 suppl 15","key":"10.1016\/j.clcc.2015.07.001_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/sonc.2002.35525","article-title":"Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures","volume":"29","author":"Gamelin","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clcc.2015.07.001_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/cncr.27732","article-title":"Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer","volume":"119","author":"Argyriou","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2015.07.001_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ctrv.2008.01.003","article-title":"A\u00a0review on oxaliplatin-induced peripheral nerve damage","volume":"34","author":"Argyriou","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clcc.2015.07.001_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00684890","article-title":"Phase I study of oxaliplatin in patients with advanced cancer","volume":"25","author":"Extra","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clcc.2015.07.001_bib8","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"de Gramont","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2015.07.001_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2407-5-116","article-title":"Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer","volume":"5","author":"Leonard","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clcc.2015.07.001_bib10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1200\/JCO.2008.19.3425","article-title":"Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity","volume":"27","author":"Park","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"2 suppl 5","key":"10.1016\/j.clcc.2015.07.001_bib11","first-page":"4","article-title":"Oxaliplatin: mechanism of action and antineoplastic activity","volume":"25","author":"Raymond","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clcc.2015.07.001_bib12","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.2002.07.056","article-title":"Acute oxaliplatin-induced peripheral nerve hyperexcitability","volume":"20","author":"Wilson","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2015.07.001_bib13","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1200\/JCO.2013.49.1514","article-title":"Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry","volume":"31","author":"Mols","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2015.07.001_bib14","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1200\/JCO.2013.52.0536","article-title":"Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB\/Alliance)","volume":"32","author":"Loprinzi","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2015.07.001_bib15","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/annonc\/mdu107","article-title":"Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT","volume":"25","author":"Hochster","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2015.07.001_bib16","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1158\/1078-0432.CCR-06-0694","article-title":"Oxaliplatin and axonal Na+ channel function in\u00a0vivo","volume":"12","author":"Krishnan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clcc.2015.07.001_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pain.2009.03.024","article-title":"Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study","volume":"144","author":"Attal","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.clcc.2015.07.001_bib18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/jnnp-2013-305334","article-title":"Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients","volume":"85","author":"Velasco","year":"2014","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clcc.2015.07.001_bib19","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1158\/0008-5472.CAN-14-2060","article-title":"A\u00a0quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy","volume":"74","author":"de Carvalho Barbosa","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.clcc.2015.07.001_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","article-title":"Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values","volume":"123","author":"Rolke","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.clcc.2015.07.001_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpain.2005.02.003","article-title":"Quantitative sensory testing: a comprehensive protocol for clinical trials","volume":"10","author":"Rolke","year":"2006","journal-title":"Eur J Pain"},{"key":"10.1016\/j.clcc.2015.07.001_bib22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ncl.2004.03.002","article-title":"The evaluation of small fiber function-autonomic and quantitative sensory testing","volume":"22","author":"Gibbons","year":"2004","journal-title":"Neurol Clin"},{"key":"10.1016\/j.clcc.2015.07.001_bib23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/ene.12353","article-title":"Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies","volume":"21","author":"Kroigard","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clcc.2015.07.001_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.clineuro.2005.08.003","article-title":"Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy","volume":"108","author":"Moghtaderi","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.clcc.2015.07.001_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1188\/11.ONF.133-142","article-title":"The validity of neuropathy and neuropathic pain measures in patients with cancer receiving taxanes and platinums","volume":"38","author":"Lavoie Smith","year":"2011","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.clcc.2015.07.001_bib26","doi-asserted-by":"crossref","first-page":"w13682","DOI":"10.4414\/smw.2012.13682","article-title":"The diagnostic value of measuring pressure pain perception in patients with diabetes mellitus","volume":"142","author":"Wienemann","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.clcc.2015.07.001_bib27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/jnnp.65.5.743","article-title":"Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group","volume":"65","author":"Martina","year":"1998","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3 Pt 2","key":"10.1016\/j.clcc.2015.07.001_bib28","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2466\/pms.1993.76.3c.1219","article-title":"Gender- and age-specific changes in motor speed and\u00a0eye-hand coordination in adults: normative values for the Finger Tapping and Grooved Pegboard Tests","volume":"76","author":"Ruff","year":"1993","journal-title":"Percept Mot Skills"},{"key":"10.1016\/j.clcc.2015.07.001_bib29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1006\/brcg.1999.1204","article-title":"Influences of handedness and gender on the grooved pegboard test","volume":"44","author":"Schmidt","year":"2000","journal-title":"Brain Cogn"},{"issue":"1-2","key":"10.1016\/j.clcc.2015.07.001_bib30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pain.2004.01.021","article-title":"Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients","volume":"109","author":"Dougherty","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.clcc.2015.07.001_bib31","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s11136-013-0379-8","article-title":"Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire","volume":"22","author":"Lavoie Smith","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.clcc.2015.07.001_bib32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.pain.2003.12.024","article-title":"Development and validation of the Neuropathic Pain Symptom Inventory","volume":"108","author":"Bouhassira","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.clcc.2015.07.001_bib33","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.clcc.2015.07.001_bib34","doi-asserted-by":"crossref","unstructured":"M. Smoragiewicz, K.R. Javaheri, Y. Yin, S. Gill, Dose intensity and survival outcomes with adjuvant FOLFOX for colon cancer. in Gastrointestinal Cancers Symposium. 2014. San Francisco, CA. J Clin Oncol 32 (suppl 3): abstract\u00a0423.","DOI":"10.1200\/jco.2014.32.3_suppl.423"},{"issue":"suppl","key":"10.1016\/j.clcc.2015.07.001_bib35","article-title":"The impact of dose reduction on survival for colon cancer patients treated with adjuvant FOLFOX","volume":"32","author":"Ibnshamsah","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2015.07.001_bib36","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1158\/1078-0432.CCR-12-0205","article-title":"Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy","volume":"18","author":"Boyette-Davis","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"Pt 10","key":"10.1016\/j.clcc.2015.07.001_bib37","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1093\/brain\/awp219","article-title":"Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy","volume":"132","author":"Park","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.clcc.2015.07.001_bib38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/ane.12331","article-title":"Reliability and accuracy of quantitative sensory testing for oxaliplatin-induced neurotoxicity","volume":"131","author":"Velasco","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clcc.2015.07.001_bib39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/15360288.2013.847519","article-title":"A\u00a0trial of Scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy","volume":"27","author":"Coyne","year":"2013","journal-title":"J\u00a0Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.clcc.2015.07.001_bib40","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1002\/cncr.10500","article-title":"Lhermitte sign and urinary retention: atypical presentation of oxaliplatin neurotoxicity in four patients","volume":"94","author":"Taieb","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2015.07.001_bib41","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.bjp.0706407","article-title":"Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels","volume":"146","author":"Webster","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clcc.2015.07.001_bib42","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/annonc\/mdr045","article-title":"Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial","volume":"23","author":"Durand","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2015.07.001_bib43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1529-8027.2007.00141.x","article-title":"The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale","volume":"12","author":"Cavaletti","year":"2007","journal-title":"J\u00a0Peripher Nerv Syst"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002815000924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002815000924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:03:34Z","timestamp":1761519814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002815000924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1533002815000924"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2015.07.001","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2015.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}